SCHEMBL6815341

SCHEMBL6815341

CC(NC(=O)N(S)c1ccc(NC(=O)c2ccccc2F)cc1C(F)(F)F)c1ccc(F)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.46
TLR8 Q9NR97 1/20 0.42
KCNB1 Q14721 1/20 0.41
KCNB2 Q92953 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
RAB9A P51151 7/20 0.41
NPC1 O15118 5/20 0.41
PTPRC P08575 3/20 0.41
CTSL P07711 1/20 0.41
PTPN1 P18031 1/20 0.41
CTSS P25774 1/20 0.41
PTPN13 Q12923 1/20 0.41
SMN1; SMN2 Q16637 4/20 0.40
HPGD P15428 3/20 0.39
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 2/20 0.39
MAPT P10636 4/20 0.39
TP53 P04637 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6816606 0.88 LMNA (0.49) LMNAKCNB1KCNB2MEN1KMT2A
SCHEMBL6816144 0.87 NPC1 (0.49) LMNAKCNB1KCNB2MEN1KMT2A
SCHEMBL6816275 0.85 HPGD (0.50) LMNAKCNB1KCNB2MEN1KMT2A
SCHEMBL6819627 0.83 LMNA (0.57) LMNAMEN1KMT2ATDP1RAB9A
SCHEMBL6816153 0.82 PTPRC (0.44) LMNAMEN1KMT2ARAB9ANPC1
SCHEMBL6816244 0.82 LMNA (0.40) LMNAMEN1KMT2ATDP1RAB9A
SCHEMBL7863607 0.80 LMNA (0.46) LMNATLR8MEN1KMT2ATDP1
SCHEMBL6815336 0.80 LMNA (0.48) LMNATLR8MEN1KMT2ATDP1
SCHEMBL6814704 0.79 TLR8 (0.49) LMNATLR8MEN1KMT2ATDP1
SCHEMBL6814461 0.78 LMNA (0.46) LMNAMEN1KMT2ATDP1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1137632-B1 THIOUREA INHIBITORS OF HERPES VIRUSES WYETH CORP (US) 2004-07-28 EP claimed
US-6207715-B1 USEFUL IN THERAPY OF DISEASES ASSOCIATED WITH HERPES VIRUSES INCLUDING HUMAN CYTOMEGALOVIRUS, HERPES SIMPLEX VIRUSES, EPSTEIN-BARR VIRUS, VARICELLA-ZOSTER VIRUS, HUMAN HERPESVIRUSES-6 AND -7, AND KAPOSI HERPES VIRUS AMERICAN HOME PRODUCTS CORPORATION 2001-03-27 US claimed
EP-1137632-B1 THIOUREA INHIBITORS OF HERPES VIRUSES WYETH CORP (US) 2004-07-28 EP disclosed
US-6207715-B1 USEFUL IN THERAPY OF DISEASES ASSOCIATED WITH HERPES VIRUSES INCLUDING HUMAN CYTOMEGALOVIRUS, HERPES SIMPLEX VIRUSES, EPSTEIN-BARR VIRUS, VARICELLA-ZOSTER VIRUS, HUMAN HERPESVIRUSES-6 AND -7, AND KAPOSI HERPES VIRUS AMERICAN HOME PRODUCTS CORPORATION 2001-03-27 US disclosed